MannKind Corp. (MNKD): Use the new label/clamp study results to...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	70
Posts	3219
Boards Moderated	0
Alias Born	07/11/2011

Denise Chanterelle

Re: None

Friday, 10/02/2015 5:23:28 PM

Friday, October 02, 2015 5:23:28 PM

Use the new label/clamp study results to gain Tier 2 insurance coverage.

Imagine you’ve seen a TV ad for Afrezza and you visit your doctor (before the above step is complete). Consider the following scenarios and how they would present barriers to prescriptions/renewals.

• What if your doctor hasn’t heard of Afrezza yet? There are many drugs and it takes time to learn.
• What if your doctor does some research and isn’t impressed by the FDA trial results? Will he/she prescribe?
• Suppose your doctor has heard of Afrezza. Suppose he prescribes! What happens if your insurance doesn’t cover it?
• What happens when the samples run out and it’s too expensive to continue

All of these scenarios can negatively affect your opinion on whether to continue/get started. If Sanofi is able to complete the 3rd step (above) before your first real impression (with the doctor) happens, the chances of success are much higher.

It's all coming together Crew! Aloha.